Efficacy and safety of simtuzumab for the treatment of primary sclerosing cholangitis: results of a phase 2b, dose-ranging, randomized, placebo-controlled trial
暂无分享,去创建一个
M. Manns | R. Chapman | Z. Goodman | H. Janssen | C. Bowlus | N. Afdhal | J. McHutchison | R. Myers | C. Levy | A. Muir | B. Eksteen | M. Subramanian | B. McColgan | C. Jia | D. Ding | A. Montaño-Loza